Euroopa Liit - eesti - EMA (European Medicines Agency)

astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - antianemilised preparaadid - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).

Euroopa Liit - eesti - EMA (European Medicines Agency)

astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastilised ained - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.

Eesti - eesti - Ravimiamet

astellas pharma d.o.o. - tamsulosiin+solifenatsiin - toimeainet modifitseeritult vabastav tablett - 0,4mg+6mg 30tk; 0,4mg+6mg 28tk; 0,4mg+6mg 100tk; 0,4mg+6mg 90tk; 0,4mg+6mg 56tk; 0,4mg+6mg 10tk; 0,4mg+6mg 20tk; 0,4mg+6mg 14tk; 0,4mg+6mg 60tk; 0,4mg+6mg 200tk

Eesti - eesti - Ravimiamet

astellas pharma d.o.o. - solifenatsiin - suukaudne suspensioon - 1mg 1ml 150ml 1tk

Eesti - eesti - Ravimiamet

astellas pharma gmbh - takroliimus - kapsel - 0,5mg 30tk; 0,5mg 50tk

Eesti - eesti - Ravimiamet

astellas pharma europe b.v. - takroliimus - infusioonilahuse kontsentraat - 5mg 1ml 1ml 10tk

Eesti - eesti - Ravimiamet

astellas pharma europe b.v. - vismutsubtsitraat - tablett - 120mg 56tk

Eesti - eesti - Ravimiamet

astellas pharma gmbh - takroliimus - kapsel - 1mg 50tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

leo pharma a/s - takroliimus - dermatiit, atoopiline - muud dermatoloogilised preparaadid - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. esinevad neli või enam korda aastas), kes on olnud esialgse vastuse maksimaalselt kuue nädala jooksul ravi kaks korda päevas takroliimus salvi (kahjustused eemaldatud, peaaegu kustutatud või kergelt kahjustatud).

Eesti - eesti - Ravimiamet

astellas ireland co. ltd - takroliimus - kõvakapsel - 0,5mg 100tk; 0,5mg 30tk; 0,5mg 50tk